Department of Morphology, Physiology and Basic Pathology, Faculty of Dentistry of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil; Department of Biomechanics, Medicine and Rehabilitation of the Locomotor System, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil; Institutional Capacity Building Program, Coordination of Earth Science and Ecology, Museum Paraense Emilio Goeldi (MPEG), Belem, PA, Brazil.
Int J Biol Macromol. 2016 Aug;89:737-45. doi: 10.1016/j.ijbiomac.2016.05.013. Epub 2016 May 6.
Matrix Metalloproteinases (MMPs) participate in many physiological and pathological processes. One major limitation to a better understanding of the role MMPs play in these processes is the lack of well-characterized chimeric proteins and characterization of their fluorescence. The specialized literature has reported on few constructs bearing MMPs fused to the sequence of the green fluorescent protein (GFP), but none of the described constructs have been intended for expression in bacteria or for purification and use in vivo. This work has tested a recombinant reporter protein containing the MMP-2 catalytic domain fused to GFP in terms of purification efficiency, degradation of substrates in solution and in zymograms, kinetic activity, GFP fluorescence, and GFP fluorescence in whole animals after injection of the purified and lyophilized fluorescent protein. This work has also characterized rhMMP-2 (recombinant human MMP-2) and inactive clones and used them as negative controls in experiments employing catMMP-2/GFP and rhMMP-2. To our knowledge, this is the first study that has fully characterized a chimeric protein with the MMP-2 catalytic domain fused to GFP, that has efficiently purified such protein from bacteria in a single-step, and that has obtained an adequate chimeric protein for injection in animals and tracking of MMP-2 fate and activity in vivo.
基质金属蛋白酶(MMPs)参与许多生理和病理过程。对 MMP 在这些过程中所起作用的更好理解的一个主要限制因素是缺乏特征明确的嵌合蛋白和对其荧光的特征描述。专业文献仅报道了少数几个将 MMP 融合到绿色荧光蛋白(GFP)序列的构建体,但所描述的构建体都不是为在细菌中表达而设计的,也无法用于纯化和在体内使用。本工作测试了一种包含 MMP-2 催化结构域与 GFP 融合的重组报告蛋白,从纯化效率、溶液和凝胶中的底物降解、动力学活性、GFP 荧光以及注射纯化和冻干荧光蛋白后的整体动物中的 GFP 荧光等方面进行了评价。本工作还对 rhMMP-2(重组人 MMP-2)和无活性克隆进行了特征描述,并将其用作 catMMP-2/GFP 和 rhMMP-2 实验中的阴性对照。据我们所知,这是首次对 MMP-2 催化结构域与 GFP 融合的嵌合蛋白进行全面特征描述的研究,该研究成功地从细菌中一步纯化了这种蛋白,并获得了足够的嵌合蛋白,可用于动物注射和追踪 MMP-2 在体内的命运和活性。